Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

Zonulin and non-celiac gluten sensitivity

Discussion in 'Gastrointestinal and Urinary' started by nandixon, Dec 10, 2015.

  1. nandixon

    nandixon Senior Member

    Note: This study, which was presented at a conference in October, was first mentioned by @Gondwanaland on another thread here. I'm giving it a thread of its own with a layperson's article from NPR. (Note that these are preliminary findings.)


See more popular forum discussions.

Share This Page